Author:
Vervoort M M,Draisma G,Fracheboud J,van de Poll-Franse L V,de Koning H J
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ (2000) Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–8: comparison of observed with predicted mortality. BMJ 321: 665–669
2. Bontenbal M, Nortier JW, Beex LV, Bakker P, Hupperets PS, Nooij MA, van Veelen H, Vreugdenhil G, Richel DJ, Blijham GH (2000) Adjuvante systemische therapie voor patienten met resectabel mammacarcinoom; richtlijn van het Nationaal Borstkanker Overleg Nederland en de Nederlandse Vereniging voor Medische Oncologie (Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for Medical Oncology). Ned Tijdschr Geneeskd 144: 984–989
3. Collette C, Collette HJ, Fracheboud J, Slotboom BJ, de Waard F (1992) Evaluation of a breast cancer screening programme – the DOM project. Eur J Cancer 28A: 1985–1988
4. De Koning HJ, Boer R, Warmerdam PG, Beemsterboer PM, van der Maas PJ (1995) Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst 87: 1217–1223
5. EBCTCG (Early Breast Cancer Trialists' Collaborative Group) (1988) Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. N Engl J Med 319: 1681–1692
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献